Fresenius Medical Care AG & Co. (NYSE:FMS)’s share price gapped up before the market opened on Monday after RBC Capital raised their price target on the stock from $35.00 to $40.00, MarketBeat reports. The stock had previously closed at $40.45, but opened at $40.90. RBC Capital currently has a sector perform rating on the stock. Fresenius Medical Care AG & Co. shares last traded at $41.80, with a volume of 61,699 shares.

Separately, Commerzbank AG cut shares of Fresenius Medical Care AG & Co. to a “hold” rating in a research report on Friday, May 29th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Fresenius Medical Care AG & Co. currently has an average rating of “Hold” and a consensus target price of $39.03.

The firm has a market cap of $25.36 billion and a P/E ratio of 24.14. The company’s 50-day moving average price is $42.55 and its 200-day moving average price is $41.20.

Fresenius Medical Care AG & Co. (NYSE:FMS) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.40 earnings per share (EPS) for the quarter, missing the analysts’ consensus estimate of $0.42 by $0.02. The firm had revenue of $4.20 billion for the quarter, compared to the consensus estimate of $4.13 billion. During the same quarter last year, the company posted $0.42 earnings per share. The business’s revenue was up 15.0% compared to the same quarter last year. Equities research analysts anticipate that Fresenius Medical Care AG & Co. will post $1.76 EPS for the current year.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD, which includes manufacturing and distributing products, such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. The Company’s health care services, referred to as care coordination services, include pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The Company also offers a range of dialysis drugs.

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

...